Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Aneuploidy of human testicular germ cell tumors is associated with amplification of centrosomes

Abstract

Testicular germ cell tumors occur in three age groups. Seminomas and nonseminomas of adults, including mature teratomas, and the precursor carcinoma in situ (CIS) are aneuploid. This also holds true for yolk sac tumors of newborn and infants, while the mature teratomas of this age are diploid. In contrast, spermatocytic seminomas occurring in the elderly contain both diploid and polyploid cells. Aneuploidy has been associated with centrosome aberrations, sometimes related to overexpression of STK15. Aneuploidy of non-neoplastic germ cells has been demonstrated in the context of male infertility, a risk factor for the development of seminoma/nonseminoma. We investigated aneuploidy, centrosome aberrations and the role of STK15 in different types of testicular germ cell tumors as well as in normal and disturbed spermatogenesis. The aneuploid seminomas and nonseminomas tumors (including CIS) showed increased numbers of centrosomes, without STK15 amplification or overexpression. Four out of six infantile teratomas had normal centrosomes, the remaining two and an infantile yolk sac tumor showed a heterogeneous pattern of cells with normal or amplified centrosomes. Spermatocytic seminomas had two, four or eight centrosomes. Germ cells in seminiferous tubules with disturbed spermatogenesis shared both aneuploidy and centrosome abnormalities with seminomas/nonseminomas and showed a more intense STK15 staining than those with normal spermatogenesis and CIS. Therefore, aneuploidy of testicular germ cell tumors is associated with amplified centrosomes probably unrelated to STK15.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  • Acar H, Kilinc M, Cora T, Aktan M and Taskapu H . (2000). Urol. Int., 64, 202–208.

  • Burke AP and Mostofi FK . (1993). J. Urol. Pathel., 1, 21–32.

  • Clausen OP, Giwercman A, Jorgensen N, Bruun E, Frimodt-Moller C and Skakkebæk NE . (1991). Cytometry, 12, 77–81.

  • Cummings OW, Ulbright TM, Eble JN and Roth LM . (1994). Hum. Pathol., 25, 54–59.

  • De Graaff WE, Oosterhuis JW, De Jong B, Dam A, Van Putten WLJ, Castedo SMMJ, Sleijfer DT and Schraffordt Koops H . (1992). Lab. Invest., 66, 166–168.

  • Dekker I, Rozeboom T, Delemarre J, Dam A and Oosterhuis JW . (1992). Cancer, 69, 993–996.

  • Doxsey SJ, Stein P, Evans L, Calarco PD and Kirschner M . (1994). Cell. 76, 639–650.

  • Eble JN . (1994). Hum Pathol., 25, 1035–1042.

  • El-Naggar AK, Ro JY, McLemore D, Ayala AG and Batsakis JG . (1992). Am. J. Surg. Pathol., 16, 611–618.

  • Faulkner SW, Leigh DA, Oosterhuis JW, Roelofs H, Looijenga LHJ and Friedlander ML . (2000). Br. J. Cancer, 83, 729–736.

  • Floyd C, Ayala AG, Logothetis CJ and Silva EG . (1988). Cancer, 61, 409–414.

  • Fukasawa K, Choi T, Kuriyama R, Rulong S and Vande Woude GF . (1996). Science, 271, 1744–1747.

  • Ghadimi BM, Sackett DL, Difilippantonio MJ, Schrock E, Neumann T, Jauho A and Auer G, Ried T . (2000). Genes Chromosomes Cancer, 27, 183–190.

  • Gillis AJM, Looijenga LHJ, De Jong B and Oosterhuis JW . (1994). Lab. Invest., 71, 874–878.

  • Giwercman A . (1992). Scand. J. Urol. Nephrol., 26, 1–47.

  • Giwercman A, Von der Maase H, Røth M and Skakkebæk NE . (1993). Lancet, 341, 384–385.

  • Glick A, Popescu N, Alexander V, Ueno H, Bottinger E and Yuspa SH . (1999). Proc. Natl. Acad. Sci. USA, 96, 14949–14954.

  • Goepfert TM, Adigum YE, Zhong L, Gay J, Medina D and Brinkley WR . (2002) Cancer Res., 62, 4115–4122.

  • Gustafson LM, Gleich LL, Fukasawa K, Chadwell J, Miller MA, Stambrook PJ and Gluckman JL . (2000). Laryngoscope, 110, 1798–1801.

  • Higgens MJ, Wang H, Stromas I, Haliotis T, Roder JC, Holden JJA and White BN . (1985). Chromosoma, 93, 77–86.

  • Hinchcliffe EH and Sluder G . (2001). Genes Dev, 15, 1167–1181.

  • Jacobsen R, Bostofte E, Engholm G, Hansen J, Olsen JH, Skakkebæk NE and Moller H . (2000a). BMJ., 321, 789–792.

  • Jacobsen R, Bostofte E, Engholm G, Hansen J, Skakkebæk NE and Moller H . (2000b). Hum Reprod., 15, 1958–1961.

  • Katayama H, Ota T, Jisaki F, Ueda Y, Tanaka T, Odashima S, Suzuki F, Terada Y and Tasuka M . (1999). J. Natl. Cancer Inst., 91, 1160–1162.

  • Kersemaekers AMF, Mayer F, Molier M, Van Weeren PC, Oosterhuis JW, Bokemeyer C and Looijenga LHJ . (2002). J. Clin. Oncol., 20, 1551–1561.

  • Kimura M, Matsuda Y, Yoshioka T and Okano Y . (1999). J. Biol. Chem., 274, 7334–7340.

  • Korn MW, Olde Weghuis DEM, Suijkerbuijk RF, Schmidt U, Otto T, Du Manoir S, Geurts van Kessel A, Seeber S and Becher R . (1996). Genes Chromosomes Cancer, 17, 78–87.

  • Kuo KK, Sato N, Mizumoto K, Maehara N, Yonemasu H, Ker CG, Sheen PC and Tanaka M . (2000). Hepatology, 31, 59–64.

  • Lahdetie J, Saari N, Ajosenpaa-Saari M and Mykkanen J . (1997). Am. J. Meet. Genet., 71, 115–121.

  • Lingle WL, Barrett SL, Negron VC, D'Assoro AB, Boeneman K, Liu W, Whitehead CM, Reynolds C and Salisbury JL . (2002). Proc. Natl. Acad. Sci. USA, 99, 1978–1983.

  • Lingle WL, Lutz WH, Ingle JN, Maihle NJ and Salisbury JL . (1998). Proc. Natl. Acad. Sci. USA, 95, 2950–2955.

  • Looijenga LHJ, Gillis AJM, Van Putten WLJ and Oosterhuis JW . (1993). Lab. Invest., 68, 211–219.

  • Looijenga LHJ, Olie RA, Van der Gaag I, van Sluijs FJ, Matoska J, Ploem-Zaaijer J, Knepfle C and Oosterhuis JW . (1994). Lab. Invest., 71, 490–496.

  • Looijenga LHJ and Oosterhuis JW . (1999). Rev. Reprod., 4, 90–100.

  • Looijenga LHJ, Oosterhuis JW, Ramaekers FC, De Jong B, Dam A, Beck JL, Sleijfer DT and Schraffordt Koops H . (1991). Lab. Invest., 64, 113–117.

  • Looijenga LHJ, Rosenberg C, Van Gurp RJHLM, Geelen E, Van Echten-Arends J, De Jong B, Mostert MC and Oosterhuis JW . (2000). J. Pathol., 19, 187–192.

  • Looijenga LHJ, Smit VTHBM, Wessels JW, Mollevanger P, Oosterhuis JW, Cornelisse CJ and Devilee P . (1990). Cytogenet. Cell Genet., 53, 216–218.

  • Lutz W, Lingle WL, McCormick D, Greenwood TM and Salisbury JL . (2001) J. Biol. Chem., 276, 20774–20780.

  • Matoska J and Talerman A . (1990). Am. J. Clin. Pathol., 94, 89–95.

  • Meek DW . (2000). Pathol. Biol. (Paris), 48, 246–254.

  • Meraldi P, Honda R and Nigg EA . (2002). EMBO J., 21, 483–492.

  • Mitelman F . (2000). Mutat. Res., 462, 247–253.

  • Miyoshi Y, Iwao K, Egawa C and Noguchi S . (2001). Int. J. Cancer, 92, 370–373.

  • Moller H and Skakkebæk NE . (1999). BMJ, 318, 559–562.

  • Mostert MC, Rosenberg C, Stoop H, Schuyer M, Timmer A, Oosterhuis JW and Looijenga LHJ . (2000). Lab. Invest., 80, 1055–1064.

  • Mostert MC, Van de Pol M, Olde Weghuis D, Suijkerbuijk RF, Geurts van Kessel A, Van Echten-Arends J, Oosterhuis JW and Looijenga LHJ . (1996). Cancer Genet. Cytogenet., 89, 146–152.

  • Mostofi FK and Sesterhenn IA . (1998). Histological Typing of Testis Tumours, 2nd edn. Springer: Berlin.

    Book  Google Scholar 

  • Oosterhuis JW, Castedo SMMJ, De Jong B, Cornelisse CJ, Dam A, Sleijfer DT and Schraffordt Koops H . (1989). Lab. Invest., 60, 14–20.

  • Ottesen AM, Kirchhoff M, Rajpert De-Meyts E, Maahr J, Gerdes T, Rose H, Lundsteen C, Meidahl Petersen P, Philip J and Skakkebæk NE . (1997). Genes Chromosomes Cancer, 20, 412–418.

  • Ouyang X, Wang X, Xu K, Jin DY, Cheung AL, Tsao SW and, Wong YC . (2001). Biochim. Biophys. Acta, 1541, 212–220.

  • Perlman EJ, Cushing B, Hawkins E and Griffin CA . (1994). Pediatr. Pathol., 14, 695–708.

  • Perlman EJ, Hu J, Ho D, Cushing B, Lauer S and, Castleberry RP . (2000). J. Pediatr. Hematol. Oncol., 22, 100–105.

  • Pihan GA, Purohit A, Wallace J, Malhotra R, Liotta L and Doxsey SJ . (2001). Cancer Res., 61, 2212–2219.

  • Robbins WA, Meistrich ML, Moore D, Hagemeister FB, Weier H-U, Cassel MJ, Wilson G, Eskenazi B and Wyrobek AJ . (1997). Nat. Genet., 16, 74–78.

  • Roelofs H, Manes T, Millan JL, Oosterhuis JW and Looijenga LHJ . (1999). J. Pathol., 189, 236–244.

  • Rosai J, Khodadoust K and Silber I . (1969). Cancer, 24, 103–116.

  • Rosenberg C, Bakker Schut T, Mostert MC, Raap AK, Oosterhuis JW and Looijenga LHJ . (1997). Cytometry, 29, 113–121.

  • Rosenberg C, Bakker Schut T, Mostert MC, Tanke HJ, Raap AK, Oosterhuis JW and Looijenga LHJ . (1999). Lab. Invest., 79, 1447–1451.

  • Rosenberg C, Mostert MC, Bakker Schut T, Van de Pol M, Van Echten-Arends J, De Jong B, Raap T, Tanke H, Oosterhuis JW and Looijenga LHJ . (1998). Genes Chromosomes Cancer, 23, 286–291.

  • Scully RE . (1961). Cancer, 14, 788–794.

  • Scully RE . (1978). Tumors of the Ovary and Maldeveloped Gonads. Scully RE (ed). Armed Forces of Pathology: Washington, DC, pp. 226–286.

    Google Scholar 

  • Sen S, Zhou H, Zhang R-D, Yoon DS, Vakar-Lopez F, Ito S, Jiang F, Johnston D, Grossman HB, Ruifrok A, Katz RL and Czerniak B . (2002). J. Natl. Cancer Inst., 94, 1320–1329.

  • Shi Q and Martin RH . (2000). Cytogenet. Cell Genet., 90, 79–83.

  • Stoop H, Van Gurp RHJLM, De Krijger R, Geurts van Kessel A, Koberle B, Oosterhuis JW and Looijenga LHJ . (2001). Lab. Invest., 81, 919–928.

  • Summersgill B, Goker H, Wber-Hall S, Huddart R, Horwich A and Shipley J . (1998). Br. J. Cancer, 77, 305–313.

  • Summersgill B, Osin P, Lu YJ, Huddart R and Shipley J . (2001). Br. J. Cancer, 85, 213–220.

  • Talerman A . (1974). J. Urol., 112, 212–216.

  • Tatsuka M, Katayama H, Ota T, Tanaka T, Odashima S, Suzuki F and Terada Y . (1998). Cancer Res., 58, 4811–4816.

  • True LD, Otis CN, Delprado W, Scully RE and Rosai J . (1988). Am. J. Surg. Pathol., 12, 75–82.

  • Van Dyk Q, Lanzendorf S, Kolm P, Hodgen GD and Mahony MC . (2000). Hum. Reprod., 15, 1529–1536.

  • Van Echten-Arends J, Van Gurp RJHLM, Stoepker M, Looijenga LHJ, De Jong B and Oosterhuis JW . (1995). Cancer Genet. Cytogenet., 85, 133–137.

  • Weber RG, Bridger JM, Benner A, Weisenberger D, Ehemann V, Reifenberger G and Lichter P . (1998). Cytogenet. Cell Genet., 83, 266–269.

  • Zhou H, Kuang J, Zhong L, Kuo W-L, Gray JW, Sahin A, Brinkley BR and Sen S . (1998). Nat. Genet., 20, 189–193.

  • Müller J, Skakkebæk NE and Parkinson MC . (1987). Int. J. Androl., 10, 147–156.

Download references

Acknowledgements

We thank Wim van Putten (Department of Statistics, Erasmus MC, Rotterdam) for supporting the statistical analysis, and Dr Jeffrey L Salisbury (Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA) for the anticentrin antibody.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Leendert H J Looijenga.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mayer, F., Stoop, H., Sen, S. et al. Aneuploidy of human testicular germ cell tumors is associated with amplification of centrosomes. Oncogene 22, 3859–3866 (2003). https://doi.org/10.1038/sj.onc.1206469

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206469

Keywords

This article is cited by

Search

Quick links